top border colored line

Watch Leading Oncology Specialists Discuss The Current Lung Cancer Landscape

Coming Soon

Epidemiology, Screening, and Staging of Lung Cancer

Treatment of Resectable and Unresectable Stage III NSCLC and LS-SCLC

Treatment of Metastatic NSCLC and ES-SCLC

Expert Panel

J. Jay Zhang, MD, PhD

J. Jay Zhang, MD, PhD

Associate Professor
UT MD Anderson Cancer Center
Houston, Texas

Steven Lin, MD, PhD

Steven Lin, MD, PhD

Associate Professor
UT MD Anderson Cancer Center
Houston, Texas

Boris Sepesi, MD

Boris Sepesi, MD

Associate Professor
UT MD Anderson Cancer Center
Houston, Texas

Program Objectives

Discuss unmet needs and incorporating a multidisciplinary approach for resectable NSCLC

Review the treatment landscape for unresectable Stage III NSCLC

Review the treatment landscape for LS-SCLC

Exelixis Logo